Veracyte, Inc. , a leading cancer diagnostics company, today announced that new data presented at the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU) demonstrate the performance and clinical ...
As Elon Musk moves to shutter the U.S. Agency for International Development, the agency’s support for the discovery of novel viruses in collaboration with the Wuhan Institute of Virology has come ...
February 14, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and ...
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
Roche Holding AG Akt 1.04% CHF232.83B ...
News Medical on MSN16h
Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancerRegeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...
Artificial Kidney Market Report Introduction 2 Artificial Kidney Market Executive Summary 3 Competitive Landscape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback